340B Stakeholders Offer Mixed Views on Trump’s Plan to Move Drug Pricing Program to CMS
340B stakeholders and attorneys offered mixed initial reactions this week to President Donald Trump’s proposal to move the 340B program [...]
*Sign up for news summaries and alerts from 340B Report